Smart contact lens could help those with vision loss see better

NCT ID NCT06989658

Not yet recruiting Symptom relief Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a miniaturized smart contact lens in 32 people—some healthy, some with Stargardt's disease—to see if it is comfortable and easy to use. The lens tracks eye movements to help with vision tasks. Researchers will check for side effects and ask participants how they liked the lens.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: miniaturized smart contact lens (scleral lens device)
What this could lead to: If successful, this could lead to a more comfortable and practical way for people with central vision loss to use eye-tracking technology, potentially improving daily activities.
What could go wrong: This is an early feasibility study with only 32 participants, so results may not apply broadly. The lens may cause discomfort or side effects, and it is not designed to treat or cure Stargardt's disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STARGARDT DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Stargardt disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STARGARDT DISEASE

Contacts and locations

Locations

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

Paris, 75012, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.